Hitoshi Okada
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
Papers in
-
- Epigenetics and DNA Methylation 8
- Cell death mechanisms and regulation 7
- Ion channel regulation and function 4
- Histone Deacetylase Inhibitors Research 4
- Immunology 11
- Immune Cell Function and Interaction 5
- Co-authors
- Tak W. Mak (15 shared papers)Andrew C. Wakeham (10 shared papers)Gordon S. Duncan (6 shared papers)Andrew Elia (4 shared papers)Tetsuo Noda (4 shared papers)Tak W. Mak (3 shared papers)Sumitaka Hasegawa (2 shared papers)Woong‐Kyung Suh (5 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (5 papers)Molecular and Cellular Biology (5 papers)The Journal of Cell Biology (3 papers)Cell Death and Disease (3 papers)The Journal of Immunology (2 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hitoshi Okada
105 papers receiving 5.7k citations
Hitoshi Okada's Hit Papers
Peers
Comparison fields: 5 of 158
- Immunology 1.2k
- Oncology 1.3k
- Molecular Biology 3.4k
- Neurology 353
- Aging 67
Countries citing papers authored by Hitoshi Okada
This map shows the geographic impact of Hitoshi Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Okada more than expected).
Fields of papers citing papers by Hitoshi Okada
This network shows the impact of papers produced by Hitoshi Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Okada. The network helps show where Hitoshi Okada may publish in the future.
Co-authors
The 25 scholars most cited alongside Hitoshi Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pathways of apoptotic and non-apoptotic death in tumour cells Hit paper breakdown → | 2004 | 859 |
| 2 | 2003 | 505 | |
| 3 | 1996 | 381 | |
| 4 | 2012 | 334 | |
| 5 | 2004 | 332 | |
| 6 | 2002 | 317 | |
| 7 | 2005 | 234 | |
| 8 | 2011 | 169 | |
| 9 | 2021 | 159 | |
| 10 | 2001 | 151 | |
| 11 | 2002 | 142 | |
| 12 | 1998 | 115 | |
| 13 | 2004 | 112 | |
| 14 | 2004 | 111 | |
| 15 | 2001 | 97 | |
| 16 | 2012 | 96 | |
| 17 | 2010 | 89 | |
| 18 | 1998 | 78 | |
| 19 | 2012 | 72 | |
| 20 | 2001 | 71 |
About Hitoshi Okada
Hitoshi Okada is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Hematology, having authored 108 papers that have together received 5.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Cell death mechanisms and regulation (7 papers), Blockchain Technology Applications and Security (6 papers), Immune Cell Function and Interaction (5 papers), Ion channel regulation and function (4 papers), Sleep and Wakefulness Research (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.3k citations), Molecular Biology (3.4k citations), Neurology (353 citations) and Aging (67 citations). Hitoshi Okada has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tak W. Mak, Andrew C. Wakeham, Gordon S. Duncan, Andrew Elia, Tetsuo Noda, Tak W. Mak, Sumitaka Hasegawa, Woong‐Kyung Suh, Shigeru Katamine and Scott Lowe. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology, The Journal of Cell Biology, Cell Death and Disease and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.